Patent US5685310A successfully refreshed from Google Patents.
US5685310A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Suspended ultra-sound microbubble imaging
Assignee: NEBRASKA UNIVERSITY OF BOARD OF REGENTS OF
•
Filing: 1995-10-10
•
Granted: 1997-11-11
•
Expires: 2015-10-10
Abstract
Abstract An ultrasonic imaging technique is disclosed which uses microbubbles as echo contrast agents. In general the method employs maintenance of an ultrasound signal while the contrast agent is intravenously injected into a mammal. Once all the contrast agent has been injected and transmission of the signal is suspended for a period of time sufficient for the microbubbles perfuse the organ of interest. Transmission of the ultrasound signal is then resumed and peak contrast images are obtained which rival more complicated imaging procedures such as nuclear resonance imaging.
Inventors
- 👤 Thomas R. Porter
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 14:31
CPC Classifications
A; A61; A61B; A61B8/00; A61B8/48; A61B8/481; A61K; A61K49/00; A61K49/06; A61K49/18; A61K49/1806; A61K49/22; A61K49/222; A61K49/223; G; G01; G01S; G01S7/00; G01S7/52; G01S7/52017; G01S7/52023; G01S7/52036; G01S7/52038
Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
65 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing said echo contrast agent into an animal by intravenous injection wherein said echo contrast agent comprises microbubbles the internal atmosphere of which contains perfluorocarbon gas; pulsing an ultrasonic transmission signal in repeating intervals so that contrast of the resulting image is enhanced, and detecting said image.
Claim 2
Independent Claim
65 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing said echo contrast agent into an animal by intravenous injection wherein said echo contrast agent comprises microbubbles the internal atmosphere of which contains perfluorocarbon gas; pulsing an ultrasonic transmission signal in repeating intervals so that contrast of the resulting image is enhanced, and detecting said image.
Claim 3
Dependent Claim
21 words
The method of claim 1 wherein said pulsed ultrasonic transmission is for a time period of approximately of 1 second intervals.
Claim 4
Dependent Claim
18 words
The method of claim 1 wherein said ultrasound signal is pulsed in coordination with said animal's cardiac cycle.
Claim 5
Independent Claim
85 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing an echo contrast agent with perfluorocarbon gas filled microbubbles into an animal by intravenous injection, wherein said perfluorocarbon gas is selected from the group consisting of perfluoromethane, perfluorobutane, perfluoroethane, and perfluoropropane or a blood insoluble gas with a molecular weight of greater than 100 g/mole; pulsing an ultrasonic transmission signal in repeating intervals so that contrast of the resulting image is enhanced; and detecting said image.
Claim 6
Independent Claim
85 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing an echo contrast agent with perfluorocarbon gas filled microbubbles into an animal by intravenous injection, wherein said perfluorocarbon gas is selected from the group consisting of perfluoromethane, perfluorobutane, perfluoroethane, and perfluoropropane or a blood insoluble gas with a molecular weight of greater than 100 g/mole; pulsing an ultrasonic transmission signal in repeating intervals so that contrast of the resulting image is enhanced; and detecting said image.
Claim 7
Dependent Claim
11 words
The method of claim 4 wherein said perfluorocarbon gas is perflurobutane.
Claim 8
Dependent Claim
19 words
The method of claim 4 wherein said microbubbles are encapsulated by a filmogenic protein such as human serum albumin.
Claim 9
Dependent Claim
14 words
The method of claim 6 wherein said human serum albumin is diluted with dextrose.
Claim 10
Dependent Claim
18 words
The method of claim 6 wherein said dilution of human serum albumin with dextrose is three to one.
Claim 11
Dependent Claim
25 words
The method of claim 6 wherein said human serum albumin is a 5% by weight solution and said dextrose is a 5% by weight solution.
Claim 12
Independent Claim
60 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing said echo contrast agent into an animal by intravenous injection; suspending ultrasonic transmission so that image contrast is enhanced; resuming ultrasonic transmission wherein said suspension and reinitiation is triggered by a point in the cardiac cycle; and detecting said ultrasonic image.
Claim 13
Independent Claim
60 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing said echo contrast agent into an animal by intravenous injection; suspending ultrasonic transmission so that image contrast is enhanced; resuming ultrasonic transmission wherein said suspension and reinitiation is triggered by a point in the cardiac cycle; and detecting said ultrasonic image.
Claim 14
Independent Claim
42 words
A method of ultrasonic myocardial renal or hepatic imaging comprising: preparing an echo contrast agent which comprises microbubbles; introducing said echo contrast agent into an animal; pulsing ultrasonic transmission in repeating intervals timed once every cardiac cycle, and thereafter, resuming ultrasonic transmission.
Claim 15
Independent Claim
42 words
A method of ultrasonic myocardial renal or hepatic imaging comprising: preparing an echo contrast agent which comprises microbubbles; introducing said echo contrast agent into an animal; pulsing ultrasonic transmission in repeating intervals timed once every cardiac cycle, and thereafter, resuming ultrasonic transmission.
Claim 16
Dependent Claim
20 words
The method of claim 11 wherein said step of suspending ultrasonic transmission is for a period of approximately 1 second.
Claim 17
Independent Claim
62 words
A method of ultrasonic myocardial, renal, or hepatic imaging comprising: preparing an echo contrast agent which comprises microbubbles by diluting a solution of 5% by weight albumin with 5% by weight dextrose by 3:1 to create a mixture; introducing said echo contrast agent into an animal; pulsing ultrasonic transmission in repeating intervals timed once every cardiac cycle; and thereafter; resuming ultrasonic transmission.
Claim 18
Independent Claim
62 words
A method of ultrasonic myocardial, renal, or hepatic imaging comprising: preparing an echo contrast agent which comprises microbubbles by diluting a solution of 5% by weight albumin with 5% by weight dextrose by 3:1 to create a mixture; introducing said echo contrast agent into an animal; pulsing ultrasonic transmission in repeating intervals timed once every cardiac cycle; and thereafter; resuming ultrasonic transmission.
Claim 19
Dependent Claim
20 words
The method of claim 13 further comprising the step of: sonicating said mixture in the presence of a perfluorocarbon gas.
Claim 20
Dependent Claim
19 words
The method of claim 13 wherein said perfluorocarbon gas is selected from the group consisting of perfluoropropane and perfluorobutane.
Claim 21
Dependent Claim
11 words
The method of claim 13 wherein said perfluorocarbon gas is perfluorobutane.
Claim 22
Independent Claim
71 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing said echo contrast agent into an animal by intravenous injection; triggering an ultrasonic transmission signal in repeating intervals so that contrast of the resulting image is enhanced, said ultrasonic transmission occurring at a pre-selected frequency, and detecting said image at an ultrasound frequency which is a harmonic interval of said transmission frequency.
Claim 23
Independent Claim
71 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing said echo contrast agent into an animal by intravenous injection; triggering an ultrasonic transmission signal in repeating intervals so that contrast of the resulting image is enhanced, said ultrasonic transmission occurring at a pre-selected frequency, and detecting said image at an ultrasound frequency which is a harmonic interval of said transmission frequency.
Claim 24
Independent Claim
72 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing said echo contrast agent into an animal by intravenous injection; triggering an ultrasonic transmission signal in repeating intervals so that contrast of the resulting image is enhanced, said ultrasonic transmission occurring at a pre-selected frequency; and detecting said image at an ultrasound frequency which is a second harmonic interval of said transmission frequency.
Claim 25
Independent Claim
72 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing said echo contrast agent into an animal by intravenous injection; triggering an ultrasonic transmission signal in repeating intervals so that contrast of the resulting image is enhanced, said ultrasonic transmission occurring at a pre-selected frequency; and detecting said image at an ultrasound frequency which is a second harmonic interval of said transmission frequency.
Claim 26
Independent Claim
98 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing an echo contrast agent with gas filled microbubbles into the vascular system of an animal; inhibiting an ultrasonic imaging signal for a period of time which allows the area to be imaged to be infused with said contrast agent; pulsing said ultrasonic imaging signal following said period to break at least some of said microbubbles and visualize said area to be imaged wherein said period is determined in consideration of the blood flow cycle timing; and detecting said image.
Claim 27
Independent Claim
98 words
A method of ultrasonic myocardial, renal, or hepatic imaging which employs an echo contrast agent having microbubbles comprising: introducing an echo contrast agent with gas filled microbubbles into the vascular system of an animal; inhibiting an ultrasonic imaging signal for a period of time which allows the area to be imaged to be infused with said contrast agent; pulsing said ultrasonic imaging signal following said period to break at least some of said microbubbles and visualize said area to be imaged wherein said period is determined in consideration of the blood flow cycle timing; and detecting said image.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-11-10 | 2001-05-12 | 2001-11-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-11-10 | 2005-05-12 | 2005-11-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-11-10 | 2009-05-12 | 2009-11-11 | $7700.00 | Window Closed / Lapsed |